Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26668/fullpdf
Reference32 articles.
1. Lung cancer: new biological insights and recent therapeutic advances;Ramalingam;CA Cancer J Clin.,2011
2. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol.,2011
3. EML4-ALK: honing in on a new target in non-small-cell lung cancer;Horn;J Clin Oncol.,2009
4. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature.,2007
5. A mouse model for EML4-ALK-positive lung cancer;Soda;Proc Natl Acad Sci U S A.,2008
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and survival outcomes of alectinib vs. crizotinib in ALK‑positive NSCLC patients with CNS metastases: A retrospective study;Oncology Letters;2024-03-22
2. A retrospective study of ensartinib-treated ALK-positive locally advanced or metastatic NSCLC patients in China;Lung Cancer Management;2023-12
3. Early-stage ALK-positive lung cancer: a narrative review;Translational Lung Cancer Research;2023-02
4. The overall survival benefit in Chinese ALK+ NSCLC patients received targeted therapies;Journal of Thoracic Disease;2022-06
5. Alectinib Together with Intracranial Therapies Improved Survival Outcomes in Untreated ALK-Positive Patients with Non-Small-Cell Lung Cancer and Symptomatic and Synchronic Brain Metastases: A Retrospective Study;OncoTargets and Therapy;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3